This inventor holds 1 USPTO granted patent. Top assignee: Leland Stanford Junior University. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Ryan D Schubert: Innovator in Demyelinating Disease Research
Introduction
Ryan D Schubert is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of medical research, particularly in understanding demyelinating diseases. His work focuses on improving patient responsiveness to treatments, which is crucial for effective healthcare.
Latest Patents
Ryan D Schubert holds a patent titled "Markers for determination of patient responsiveness." This patent provides compositions and methods for classifying individuals suffering from demyelinating diseases into groups that indicate their responsiveness or lack thereof to treatment with J3-interferon (IFNJ3) acting therapy. The research demonstrates that effective immunomodulatory treatment of demyelinating diseases, such as multiple sclerosis and neuromyelitis optica, is associated with an increase in circulating transitional B cells in patients.
Career Highlights
Ryan is affiliated with Leland Stanford Junior University, where he continues to advance his research in the medical field. His innovative approach to understanding patient treatment responses has positioned him as a key figure in the study of demyelinating diseases.
Collaborations
Ryan has collaborated with esteemed colleagues, including Jeffrey Edward Dunn and Robert C Axtell. These partnerships have further enriched his research and contributed to the advancement of knowledge in his area of expertise.
Conclusion
Ryan D Schubert's work in the field of demyelinating diseases exemplifies the impact of innovative research on patient care. His contributions through patents and collaborations highlight the importance of understanding treatment responsiveness in improving healthcare outcomes.